Masahiro Torasawa, Medical Oncologist at Juntendo University, shared a post on X:
“Nearly 30 thoracic oncology abstracts from Japan will be presented at ASCO 2026 – including ours!
China’s momentum is truly impressive.
This makes me even more motivated to contribute to:
- Japan-led studies selected for oral presentation .
- Multinational research led from Japan.
- A stronger global impact in lung cancer research.”
Other articles featuring Dr. Torasawa on OncoDaily.